ICD-10-CM Billable Code

M11.20

Other chondrocalcinosis, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Chondrocalcinosis, classified under ICD-10 code M11.20, refers to a condition characterized by calcium crystal deposits in cartilage, leading to joint issues. Often called calcium pyrophosphate deposition disease (CPPD), this condition can affect various joints and cause discomfort or mobility problems. While sometimes asymptomatic, chondrocalcinosis may manifest as joint pain, swelling, and stiffness, particularly in older adults or those with underlying health conditions. Recognizing the signs and understanding potential causes can help in effective management of the condition.

Causes & Symptoms

Clinical Causes: Aging: The risk of calcium crystal deposits increases with age, especially after 60 years. Genetics: Some individuals inherit tendencies toward calcium crystal accumulation. Joint injury or trauma: Past injuries can predispose joints to crystal deposits. Metabolic disorders: Conditions such as hyperparathyroidism, hemochromatosis, and hypophosphatasia can contribute to calcium crystal formation. Degenerative joint diseases: Osteoarthritis may be associated with or exacerbate chondrocalcinosis. Other inflammatory diseases: Conditions like gout or septic arthritis can co-occur or influence calcium deposition.

Key Symptoms: Joint pain, especially after periods of inactivity or in cold weather Swelling around affected joints Stiffness, particularly in the mornings or after long periods of rest Limited range of motion in affected joints Possible warmth and tenderness over the joint In some cases, no noticeable symptoms; the condition is detected incidentally during imaging

Diagnostic & Treatment

Diagnosis Path: Diagnosing chondrocalcinosis involves a combination of clinical evaluation and imaging tests. Medical professionals typically use X-rays to identify calcium deposits in cartilage. Synovial fluid analysis may be performed, where fluid extracted from the joint is examined under a microscope to detect calcium pyrophosphate crystals. Blood tests can help detect underlying metabolic disorders that might contribute to the condition. Accurate diagnosis is essential to distinguish chondrocalcinosis from other joint disorders such as gout or osteoarthritis.

Treatment Protocols: While there is no cure for chondrocalcinosis, various strategies can help manage symptoms and improve joint function. Treatment approaches may include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Colchicine to decrease crystal formation and prevent attacks - Corticosteroid injections directly into the affected joint for severe inflammation - Physical therapy aimed at strengthening muscles around the joint and maintaining mobility - Lifestyle modifications such as weight management and low-impact exercises - Addressing underlying metabolic conditions through appropriate medical interventions Monitoring and regular check-ups can help manage the condition effectively, especially if symptoms worsen or new joints become affected.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.20 a billable ICD-10 code?
Yes, M11.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.20?
Clinical documentation must specify the nature of Other chondrocalcinosis, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference